Difference between revisions of "Template:Lipid storage disorders"
Jump to navigation
Jump to search
imported>Tom (LT) m (per Template_talk:Medicine_navs#Background_colours, remove unnecessary and confusing background colours using AWB) |
imported>NSH002 (tidy up) |
||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name | + | | name = Lipid storage disorders |
| − | | title = ([[Lysosomal storage disease|LSD]]) [[Inborn error of metabolism|Inborn error]] of [[Inborn error of lipid metabolism|lipid metabolism]]: [[lipid storage disorder]]s ([[ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases#(E75) Lipids|E75]], [[List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders#Other metabolic and immunity disorders (270–279)|272.7–272.8]]) | + | | title = ([[Lysosomal storage disease|LSD]]) [[Inborn error of metabolism|Inborn error]] of [[Inborn error of lipid metabolism|lipid metabolism]]: [[lipid storage disorder]]s ([[ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases#(E75) Lipids|E75]], [[List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders#Other metabolic and immunity disorders (270–279)|272.7–272.8]]) |
| − | + | | state = {{{state<includeonly>|autocollapse</includeonly>}}} | |
| − | | state = {{{state|autocollapse}}} | + | | listclass = hlist |
| + | | group1 = [[Sphingolipidoses]]<br />(to [[ceramide]]) | ||
| + | | list1 = {{Navbox|child | ||
| − | + | | group1 = From [[ganglioside]]<br />([[Gangliosidosis|gangliosidoses]]) | |
| − | + | | list1 = | |
| − | |||
| − | |||
| − | |||
| − | | group1 = From [[ganglioside]]<br />([[Gangliosidosis|gangliosidoses]]) | ||
| − | | list1 | ||
* [[Ganglioside]]: [[GM1 gangliosidoses]] | * [[Ganglioside]]: [[GM1 gangliosidoses]] | ||
* [[GM2 gangliosidoses]] ([[Sandhoff disease]] | * [[GM2 gangliosidoses]] ([[Sandhoff disease]] | ||
| Line 18: | Line 15: | ||
* [[GM2-gangliosidosis, AB variant|AB variant]]) | * [[GM2-gangliosidosis, AB variant|AB variant]]) | ||
| − | | group2 = From [[globoside]] | + | | group2 = From [[globoside]] |
| − | | list2 | + | | list2 = |
* [[Globotriaosylceramide]]: [[Fabry disease|Fabry's disease]] | * [[Globotriaosylceramide]]: [[Fabry disease|Fabry's disease]] | ||
| − | |group3 | + | | group3 = From [[sphingomyelin]] |
| − | |list3 | + | | list3 = |
* [[Sphingomyelin]]: ''phospholipid:'' [[Niemann–Pick disease]] ([[Niemann–Pick disease, SMPD1-associated|SMPD1-associated]] | * [[Sphingomyelin]]: ''phospholipid:'' [[Niemann–Pick disease]] ([[Niemann–Pick disease, SMPD1-associated|SMPD1-associated]] | ||
| − | * [[Niemann–Pick disease, type C|type C]]) | + | * [[Niemann–Pick disease, type C|type C]]) |
| − | + | * [[Glucocerebroside]]: [[Gaucher's disease]] | |
| − | | group4 = From [[sulfatide]]<br />([[Sulfatidosis|sulfatidoses]] | + | | group4 = From [[sulfatide]]<br />([[Sulfatidosis|sulfatidoses]] |
* [[leukodystrophy]]) | * [[leukodystrophy]]) | ||
| − | | list4 | + | | list4 = |
* [[Sulfatide]]: [[Metachromatic leukodystrophy]] | * [[Sulfatide]]: [[Metachromatic leukodystrophy]] | ||
| − | * [[Multiple sulfatase deficiency]] | + | * [[Multiple sulfatase deficiency]] |
| − | + | * [[Galactocerebroside]]: [[Krabbe disease]] | |
| − | |group5 | + | | group5 = To [[sphingosine]] |
| − | |list5 | + | | list5 = |
* [[Ceramide]]: [[Farber disease]] | * [[Ceramide]]: [[Farber disease]] | ||
| − | }} | + | }} |
| − | | group2 = [[Neuronal ceroid lipofuscinosis|NCL]] | + | | group2 = [[Neuronal ceroid lipofuscinosis|NCL]] |
| − | | | + | | list2 = |
| − | * [[Infantile neuronal ceroid | + | * [[Infantile neuronal ceroid lipofuscinosis|Infantile]] |
* [[Jansky–Bielschowsky disease]] | * [[Jansky–Bielschowsky disease]] | ||
* [[Batten disease]] | * [[Batten disease]] | ||
| − | | group3 = Other | + | | group3 = Other |
| − | | | + | | list3 = |
* [[Cerebrotendineous xanthomatosis]] | * [[Cerebrotendineous xanthomatosis]] | ||
* [[Cholesteryl ester storage disease]] ([[Lysosomal acid lipase deficiency]]/[[Wolman disease]]) | * [[Cholesteryl ester storage disease]] ([[Lysosomal acid lipase deficiency]]/[[Wolman disease]]) | ||
| − | * [[Sea-blue | + | * [[Sea-blue histiocytosis]] |
| − | | belowstyle = background: transparent; padding: 0px; | + | | belowstyle = background: transparent; padding: 0px; |
| − | | below = {{Metabolic navs}} | + | | below = {{Metabolic navs}} |
}}<noinclude> | }}<noinclude> | ||
{{collapsible option}} | {{collapsible option}} | ||
| − | |||
[[Category:Metabolic disorder templates]] | [[Category:Metabolic disorder templates]] | ||
| − | |||
</noinclude> | </noinclude> | ||
Revision as of 10:04, 6 June 2015
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Lipid storage disorders|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Lipid storage disorders|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Lipid storage disorders|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.